Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MOR MorphoSys > Detailed Quotes

MOR MorphoSys

5.400
-0.090-1.64%
Close 09/29 16:00 ET
5.4000.0000.00%
Post Mkt Price 09/29 16:47 ET
High
5.620
Open
5.610
Turnover
345.70K
Low
5.282
Pre Close
5.490
Volume
63.41K
Market Cap
737.71M
P/E(TTM)
Loss
52wk High
12.450
Shares
136.61M
P/E(Static)
Loss
52wk Low
4.070
Float Cap
708.42M
Bid/Ask %
-14.29%
Historical High
37.961
Shs Float
131.19M
Volume Ratio
0.61
Historical Low
4.070
Dividend TTM
--
Div Yield TTM
--
P/B
-26.34
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.05%
Amplitude
6.16%
Avg Price
5.451
Lot Size
1
Float Cap
708.42M
Bid/Ask %
-14.29%
Historical High
37.961
Shs Float
131.19M
Volume Ratio
0.61
Historical Low
4.070
Dividend TTM
--
P/B
-26.34
Dividend LFY
--
Turnover Ratio
0.05%
Amplitude
6.16%
Avg Price
5.451
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
CEO: Mr. Jean-Paul Kress
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...